Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary

DEDE, D.; GUMUSKAYA, B.; Guler, GÜLNUR; ONAT, DEMİRALİ; ALTUNDAG, K.; ÖZIŞIK, YASİN

Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary

Atıf İçin Kopyala

DEDE D. S., GUMUSKAYA B., Guler G., ONAT D., ALTUNDAG K., ÖZIŞIK Y. Y.

JOURNAL OF BUON, cilt.18, sa.2, ss.366-371, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 2
Basım Tarihi: 2013
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.366-371
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.